Please login to the form below

Not currently logged in
Email:
Password:

Shire promotes Joanne Cordeiro to chief human resources officer

But loses CFO Jeff Poulton, who is moving to Boston start-up Indigo

Biotechnology group Shire has appointed Joanne Cordeiro as its new chief human resources officer and a member of the executive committee.

Cordeiro joined Shire back in March 2011 and she has been serving as its interim head of human resources since March 2017.

She said: “It’s an honour to accept this appointment and I look forward to the opportunity to continue building on the expertise and passion of my colleagues at Shire, attracting top talent to our organisation, and working with the rest of the executive committee, all of whom are dedicated to improving the lives of the patients we serve.”

Before joining Shire, Cordeiro served in various human resources management and executive search roles at Teradyne, Avid Technology and Sybase.

Dr Flemming Ornskov, Shire's chief executive officer, said: “Joanne’s dedication, skill, and expertise have been an invaluable resource in the successful integration of Baxalta into the Shire business.

“She is a trusted partner to the entire management team and a passionate supporter of our in-house talent and leadership development programmes, which are crucial to our business.”

Meanwhile, Shire is set to lose chief financial officer (CFO), Jeff Poulton, who will be moving to serve at Indigo - a start-up company based in Boston.

During a transitional period, Poulton will remain on Shire's executive committee and its board of directors.

29th August 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics